News
W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...
11h
ScienceAlert on MSNPromising New Drug For Weight Loss Works With Just One Monthly DoseDrugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss. Another medication in the same ...
A clinical trial has shown that Ozempic improves blood glucose levels and weight loss in overweight type 1 diabetics who use ...
Drug services provider Medtide (3880.HK) is looking to raise HK$514 million (410 million yuan or $65.48 million) in a listing ...
Altimmune, Inc.'s Pemvidutide shows promise in MASH treatment with liver improvements and safety, despite market overreaction. Click for my ALT stock update.
9h
Zacks Investment Research on MSNCan LLY's Next-Generation Obesity Pipeline Fuel Further Growth?Eli Lilly LLY has experienced significant growth in the past few years, particularly driven by the success of its popular ...
10h
Verywell Health on MSNDoes Ozempic Shrink the Size of Your Hands?Ozempic hands' is the latest strange semaglutide side effect, but experts say it's a common and normal weight loss outcome.
She began using Wegovy, the version of Ozempic approved for weight loss, after struggling with obesity. She reveals which foods to avoid on a GLP-1 and how to prevent muscle loss.
9h
Verywell Health on MSNHow Long Does Ozempic Stay in Your System?How long does Ozempic stay in your system? What to expect after stopping, including clearance time, side effects, and factors that influence it.
For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...
Eli Lilly poised for 30-50% growth in 12 months with a strong value and growth nexus. Click here to read more on LLY stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results